...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: As Pfizer charges ahead....

I think some of the clinical centers doing covid drug trials must be making buckets of money. Apart from the academic centers, I doubt if they will be doing what they should be - giving priority to the drugs with the best credentials. Money will come into it. If RVX offers $x per patient and BP offers $10x, you can guess the outcome. So the choice of center would be critical. There have been many drug trials, but few new effective drugs, other than antibodies. Why is that? 

Share
New Message
Please login to post a reply